Reuters logo
BRIEF-ELEVEN BIOTHERAPEUTICS Q1 LOSS PER SHARE $0.25
May 4, 2017 / 11:55 AM / 5 months ago

BRIEF-ELEVEN BIOTHERAPEUTICS Q1 LOSS PER SHARE $0.25

May 4 (Reuters) - Eleven Biotherapeutics Inc

* ELEVEN BIOTHERAPEUTICS REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.25

* Q1 REVENUE $400,000 VERSUS $200,000

* ELEVEN BIOTHERAPEUTICS INC - EXPECTS TO HAVE CASH TO FUND RESEARCH AND DEVELOPMENT PROGRAMS AND OPERATIONS INTO EARLY 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below